Skip to content

Clinical trials

Phase 1 Dermatitis, Atopic trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Dermatitis, Atopic Phase: Phase 1 Country / region: China Clear all

34 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20191
20211
20222
20238
20246
20259
20267

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed20
Recruiting6
Unknown status4
Not yet recruiting3
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Jiangsu vcare pharmaceutical technology co., LTD4
Mabwell (Shanghai) Bioscience Co., Ltd.2
Qilu Pharmaceutical Co., Ltd.2
SinoMab BioScience Ltd2
Amgen1
Bambusa Therapeutics1
BeiGene1
Chengdu Suncadia Medicine Co., Ltd.1
Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.1
Cutia Therapeutics(Wuxi)Co.,Ltd1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Dermatitis, Atopic34
Asthma3
Hidradenitis Suppurativa2
Pulmonary Disease, Chronic Obstructive2
Arthritis, Rheumatoid1
Autoimmune Diseases1
Eczema1
Inflammatory Bowel Diseases1

Trials

Showing 1 to 25 of 34. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.